Shallow WGS of individual CTCs identifies actionable targets for
4.5 (752) · $ 13.50 · In stock
Functional validation of novel ESR1 p.A569S mutation demonstrates
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
Frontiers Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Research articles British Journal of Cancer
Representative images of histological staining and 18F-FDG PET/CT
PDF) Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers
Workflow for single CTC detection and molecular analysis. Each
Publications - Professor Simak Ali
Frontiers Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review
Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer - De Mattos‐Arruda - 2016 - Molecular Oncology - Wiley Online Library
